Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: COVID-19

In brief

The primary objective is to assess the impact of hydroxychloroquine in hospitalized patients with COVID-19 and risk factors for severe/critical disease.

Key facts

Study ID
NCT04429867
Run by
WellStar Health System
People needed
700
Starts
2020-05-07
Expected to finish
2020-12-07
Last updated by the study team
2020-06-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.